Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_assertion type Assertion NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_head.
- NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_assertion description "[Metastatic pancreatic cancer cases had fewer solitary lung lesions (5 (15%) versus 37 (95%) for lung primaries; P=0.0001), more tumors with pure (100%) mucinous morphology (16 (50%) versus 9 (23%) for lung primaries; P=0.0037), and more frequent KRAS mutations (24 (75%) versus 18 (46%) for lung primaries; P=0.0093).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_provenance.
- NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_assertion evidence source_evidence_literature NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_provenance.
- NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_assertion SIO_000772 23887294 NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_provenance.
- NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_assertion wasDerivedFrom befree-20150227 NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_provenance.
- NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_assertion wasGeneratedBy ECO_0000203 NP527792.RAsqP6Cj4dKxjcyme7ThaUYMjUpzutDWZ3ajjEI_6jPFY130_provenance.